WO1994027449A1 - Monohydrate dextrose or glucose composition - Google Patents
Monohydrate dextrose or glucose composition Download PDFInfo
- Publication number
- WO1994027449A1 WO1994027449A1 PCT/NZ1994/000042 NZ9400042W WO9427449A1 WO 1994027449 A1 WO1994027449 A1 WO 1994027449A1 NZ 9400042 W NZ9400042 W NZ 9400042W WO 9427449 A1 WO9427449 A1 WO 9427449A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- composition
- homeopathic
- potency
- titration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a composition for the treatment of a "hangover" i.e. the after-effects of excessive consumption of ethyl alcohol by a human being.
- An object of the invention is the provision of a composition which can be taken as a single treatment (in one or more doses) to counteract a hangover.
- the present invention provides a composition including:- a major proportion of monohydrate dextrose or glucose in combination with the following compounds:
- liver activity As the liver increases its normal rate of breaking down glycogen into blood sugar, to restore the optimum blood sugar level.
- Continual or frequent such increase in liver activity can lead to cirrhosis of the liver.
- the brain uses about 25% of available blood sugar, and so is particularly rapidly effected by a drop in blood sugar levels:- hence the symptoms of slurred speech, memory lapses, headaches, loss of co-ordination, blurred vision, personality changes, and so on commonly associated with alcohol consumption.
- Monohydrate dextrose breaks down to glucose in the body, and thus both monohydrate dextrose and glucose are quickly and readily assimilated into the blood stream to boost the blood sugar level and help prevent liver damage and counteract brain disfunction.
- magnesium and potassium salts are magnesium sulphate, magnesium oxide, and potassium phosphate.
- magnesium and potassium salts may be used.
- magnesium and potassium salts and vitamin C are much more readily and easily absorbed into the system if taken into the system with monohydrate dextrose or glucose:- the monohydrate dextrose or glucose effectively coats said other constituents and prevents them from being destroyed by stomach acids, and also speeds their circulation around the system.
- Zinc oxide assists the pancreas with the production of insulin, and hence facilitates the absorption of glucose into the blood.
- Zinc oxide also is known to be effective in detoxifying the system i.e. combatting the after-effects of alcohol.
- vitamin B6 in the composition considerably increases the rate of activity of the composition and thus gives more rapid relief to a user. It appears that vitamin B6 and magnesium salts are synergistic i.e. the presence of one increases the effectiveness of the other, and thus reduces the amount of each needed in the composition to achieve the desired effect.
- the constituents of the composition act to raise the user's blood sugar level and replenish lost vitamin C, magnesium and potassium, and also interact with each other to mutually increase their effectiveness and to speed their assimilation into the system.
- composition also may contain one or more of the following:
- a preferred embodiment of the present composition comprises:
- the composition is in the form of a powder, and is taken dissolved in water or in tablet form. It has been found that the composition is more effective if the user lies on the right side after taking the composition, because this allows the composition to pass more quickly though the duodenum into the intestine, for absorption into the system.
- the composition may be prepared in liquid form, and drunk or given by injection.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU65844/94A AU676314B2 (en) | 1993-05-26 | 1994-05-10 | Monohydrate dextrose or glucose composition |
| EP94913846A EP0700255A4 (en) | 1993-05-26 | 1994-05-10 | Monohydrate dextrose or glucose composition |
| CA002162877A CA2162877C (en) | 1993-05-26 | 1994-05-10 | Monohydrate dextrose or glucose composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ24770193 | 1993-05-26 | ||
| NZ247701 | 1993-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1994027449A1 true WO1994027449A1 (en) | 1994-12-08 |
Family
ID=19924357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/NZ1994/000042 Ceased WO1994027449A1 (en) | 1993-05-26 | 1994-05-10 | Monohydrate dextrose or glucose composition |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0700255A4 (en) |
| CN (1) | CN1124444A (en) |
| AU (1) | AU676314B2 (en) |
| CA (1) | CA2162877C (en) |
| WO (1) | WO1994027449A1 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997026897A1 (en) * | 1996-01-24 | 1997-07-31 | Edwina Margaret Piper | Compositions for the treatment of migraine, containing potassium, magnesium and pyridoxine |
| FR2748936A1 (en) * | 1996-05-23 | 1997-11-28 | Clergeaud Jean | Composition to lessen alcohol passing into the bloodstream |
| FR2748904A1 (en) * | 1996-05-27 | 1997-11-28 | Turpin Veronique | Personalised nutritional complement containing Schuessler salts |
| WO1999026492A1 (en) * | 1997-11-21 | 1999-06-03 | Turpin Veronique | Nutritional additive based on schuelssler biochemical salts |
| KR100309715B1 (en) * | 1998-04-07 | 2001-12-28 | 이명희 | Composition having function for preventing toxicity and hangover of alcohol by activation of citric acid cycle |
| WO2008156297A3 (en) * | 2007-06-19 | 2009-02-19 | Cj Cheiljedang Corp | Composition for preventing or treating katzenjammer |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101498780B1 (en) * | 2013-04-18 | 2015-03-04 | 씨제이제일제당 (주) | Composition for preventing or treating hangover |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0087068A1 (en) * | 1982-02-12 | 1983-08-31 | Thomas Moses Dr. Beck | Nutritional supplement |
| US4710387A (en) * | 1984-11-09 | 1987-12-01 | Melkunte Holland B.V. | Nutritional supplement preparation intended for pregnant and breast-feeding women based on milk constituents as well as a process for preparing it |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH370631A (en) * | 1957-05-03 | 1963-07-15 | Heinrich Dr Vogler | Process for the manufacture of a preparation intended as an additive to food and beverages |
| US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
-
1994
- 1994-05-10 CN CN94192255A patent/CN1124444A/en active Pending
- 1994-05-10 EP EP94913846A patent/EP0700255A4/en not_active Withdrawn
- 1994-05-10 AU AU65844/94A patent/AU676314B2/en not_active Ceased
- 1994-05-10 CA CA002162877A patent/CA2162877C/en not_active Expired - Fee Related
- 1994-05-10 WO PCT/NZ1994/000042 patent/WO1994027449A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0087068A1 (en) * | 1982-02-12 | 1983-08-31 | Thomas Moses Dr. Beck | Nutritional supplement |
| US4710387A (en) * | 1984-11-09 | 1987-12-01 | Melkunte Holland B.V. | Nutritional supplement preparation intended for pregnant and breast-feeding women based on milk constituents as well as a process for preparing it |
| US5108767A (en) * | 1991-06-10 | 1992-04-28 | Abbott Laboratories | Liquid nutritional product for persons receiving renal dialysis |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP0700255A4 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997026897A1 (en) * | 1996-01-24 | 1997-07-31 | Edwina Margaret Piper | Compositions for the treatment of migraine, containing potassium, magnesium and pyridoxine |
| FR2748936A1 (en) * | 1996-05-23 | 1997-11-28 | Clergeaud Jean | Composition to lessen alcohol passing into the bloodstream |
| FR2748904A1 (en) * | 1996-05-27 | 1997-11-28 | Turpin Veronique | Personalised nutritional complement containing Schuessler salts |
| WO1999026492A1 (en) * | 1997-11-21 | 1999-06-03 | Turpin Veronique | Nutritional additive based on schuelssler biochemical salts |
| KR100309715B1 (en) * | 1998-04-07 | 2001-12-28 | 이명희 | Composition having function for preventing toxicity and hangover of alcohol by activation of citric acid cycle |
| WO2008156297A3 (en) * | 2007-06-19 | 2009-02-19 | Cj Cheiljedang Corp | Composition for preventing or treating katzenjammer |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2162877C (en) | 2004-04-13 |
| EP0700255A4 (en) | 1997-02-26 |
| EP0700255A1 (en) | 1996-03-13 |
| CA2162877A1 (en) | 1994-12-08 |
| AU6584494A (en) | 1994-12-20 |
| CN1124444A (en) | 1996-06-12 |
| AU676314B2 (en) | 1997-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5053396A (en) | Therapeutic composition | |
| US5614224A (en) | Nutritional supplement for diabetics | |
| EP0669083B1 (en) | Creatine beverage and producing process thereof | |
| US5730988A (en) | Nutritional supplements for improving glucose metabolism | |
| Rastogi et al. | Selenium and lead: mutual detoxifying effects | |
| EP0271489B1 (en) | Therapeutic composition | |
| US6867176B2 (en) | Method for preparing zinc-oligopeptide easily absorbable by the human body | |
| CA2429117C (en) | Remedy for diabetes mellitus | |
| CA2162877C (en) | Monohydrate dextrose or glucose composition | |
| KR100613618B1 (en) | How to sustain the oxidative metabolism that occurs with exercise and sports foods | |
| DE68903147T2 (en) | COMPOSITIONS AND METHOD FOR OBTAINING AN IMPROVED PHYSIOLOGICAL REACTION IN LIFE EXERCISES. | |
| US5639482A (en) | Composition for control and prevention of diabetic retinopathy | |
| EP0496479B1 (en) | NADH and NADPH as energy-substitutes | |
| NZ265404A (en) | Composition for treatment of hangover | |
| RS54412B1 (en) | COMPOSITION OF BEE HONEY AND L-ALANYL-L-GLUTAMINE | |
| JP2970957B2 (en) | Refined pollen nutritional preparation | |
| US20090062231A1 (en) | Appetite Suppressant Composition and Method of Appetite Suppression | |
| JP2002265365A (en) | Neutrophil function inhibitor | |
| JP3793239B2 (en) | Inhibitor of acetaldehyde toxicity | |
| JP3241173B2 (en) | Bath additive | |
| KR20120119686A (en) | A functional beverage composition comprising l-arginine, vitamin c, vitamin b complex, vitamin a, vitamin e and potassium iodide as main ingredients | |
| KR20120110955A (en) | A functional beverage composition comprising taurine, inositol, vitamin c, vitamin b complex, potassium iodide as main ingredients | |
| JP2007314560A (en) | Agents that sustain oxidative metabolism that accompanies exercise | |
| US4474801A (en) | α-Amino-γ-butyrolactones for treating alcohol dependence | |
| Gray | The treatment of diabetes mellitus with insoluble insulin compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 94192255.3 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KG KP KR KZ LK LU LV MD MG MN MW NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 265404 Country of ref document: NZ |
|
| ENP | Entry into the national phase |
Ref document number: 1995 537797 Country of ref document: US Date of ref document: 19951027 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1994913846 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2162877 Country of ref document: CA |
|
| WWP | Wipo information: published in national office |
Ref document number: 1994913846 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1994913846 Country of ref document: EP |